pI: 9.0582 |
Length (AA): 412 |
MW (Da): 47579 |
Paralog Number:
0
Signal peptide: N | GPI Anchor: N | Predicted trans-membrane segments: 8
Targets have been classified into druggability groups (DG) according to their druggability score in network driven prioritizations. DGs range from 1 to 5; the higher the group number, the higher the chance of the target to be druggable
Modbase 3D models:
There is 1 model calculated for this protein. More info on
this model, including the
model itself is available at:
Modbase
Target Beg | Target End | Template | Template Beg | Template End | Identity | Evalue | Model Score | MPQS | zDope |
---|---|---|---|---|---|---|---|---|---|
28 | 127 | 3udc (A) | 20 | 104 | 32.00 | 0.25 | 0.09 | 0.172218 | 2.12 |
Help me make sense of these data.
A more detailed description of these scores is available at the Modbase Model Evaluation Help Pages, and in the papers referenced therein.
PDB Structures:
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Upper 80-100% percentile | intra-erythrocytic - 0 hs, intra-erythrocytic - 8 hs, intra-erythrocytic - 16 hs, intra-erythrocytic - 24 hs, intra-erythrocytic - 32 hs, intra-erythrocytic - 40 hs, intra-erythrocytic - 48 hs, gametocyte, merozoite, sporozoite, early ring, early schizont, early trophozoite, late ring, late schizont, late trophozoite, Oocyst, Ring, Female Gametocyte. | Otto TD PlasmoDB Zanghi G Lasonder E |
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Upper 60-80% percentile | Sporozoite, Male Gametocyte. | Zanghi G Lasonder E |
Lasonder E | Integrated transcriptomic and proteomic analyses of P. falciparum gametocytes. Molecular insight into sex-specific processes and translational repression. |
Zanghi G | A Specific PfEMP1 Is Expressed in P. falciparum Sporozoites and Plays a Role in Hepatocyte Infection. |
PlasmoDB | Data on upregulation of P. falciparum genes in different life cycle stages, combined from several microarray experiments available in PlasmoDB |
Otto TD | New insights into the blood-stage transcriptome of Plasmodium falciparum using RNA-Seq. |
Ortholog group members (OG5_128374)
Species | Accession | Gene Product |
---|---|---|
Arabidopsis thaliana | AT2G03120 | signal peptide peptidase |
Brugia malayi | Bm1_39720 | Hypothetical 52.8 kDa protein T05E11.5 in chromosome IV |
Caenorhabditis elegans | CELE_T05E11.5 | Protein IMP-2 |
Cryptosporidium hominis | Chro.60109 | multi-pass transmembrane protein |
Cryptosporidium parvum | cgd6_840 | shanti/Ykl100cp/Minor histocompatibility antigen H13-like; presenilin, signal peptide peptidase family, with 10 transmembrane do |
Dictyostelium discoideum | DDB_G0292836 | peptidase A22B family protein |
Drosophila melanogaster | Dmel_CG11840 | Signal peptide peptidase |
Echinococcus granulosus | EgrG_000084000 | Minor histocompatibility antigen H13 |
Entamoeba histolytica | EHI_031250 | signal peptidase, putative |
Echinococcus multilocularis | EmuJ_000084000 | Minor histocompatibility antigen H13 |
Giardia lamblia | GL50803_8429 | Minor histocompatibility antigen H13 |
Homo sapiens | ENSG00000101294 | histocompatibility (minor) 13 |
Leishmania braziliensis | LbrM.29.0980 | signal peptide peptidase, putative,aspartic peptidase, clan AD, family A22B, putative |
Leishmania donovani | LdBPK_290990.1 | signal peptide peptidase, putative |
Leishmania infantum | LinJ.29.0990 | signal peptide peptidase, putative,aspartic peptidase, clan AD, family A22B, putative |
Leishmania major | LmjF.29.0910 | signal peptide peptidase, putative,aspartic peptidase, clan AD, family A22B, putative |
Leishmania mexicana | LmxM.08_29.0910 | signal peptide peptidase, putative,aspartic peptidase, clan AD, family A22B, putative |
Loa Loa (eye worm) | LOAG_11844 | hypothetical protein |
Loa Loa (eye worm) | LOAG_04660 | hypothetical protein |
Mus musculus | ENSMUSG00000019188 | histocompatibility 13 |
Neospora caninum | NCLIV_051010 | signal peptide peptidase domain-containing protein, putative |
Oryza sativa | 4328088 | Os02g0117400 |
Oryza sativa | 4338901 | Os05g0436400 |
Plasmodium berghei | PBANKA_1320700 | signal peptide peptidase, putative |
Plasmodium falciparum | PF3D7_1457000 | signal peptide peptidase |
Plasmodium knowlesi | PKNH_1224800 | signal peptide peptidase, putative |
Plasmodium vivax | PVX_117615 | signal peptide peptidase, putative |
Plasmodium yoelii | PY06507 | Homo sapiens dJ324O17.1.2-related |
Saccharomyces cerevisiae | YKL100C | hypothetical protein |
Schistosoma japonicum | Sjp_0212410 | ko:K09595 minor histocompatibility antigen H13, putative |
Schistosoma mansoni | Smp_099430 | signal peptide peptidase |
Schmidtea mediterranea | mk4.001765.04 | Intramembrane protease 2 |
Trypanosoma brucei gambiense | Tbg972.3.5500 | signal peptide peptidase, putative,aspartic peptidase, clan AD, family A22B, putative |
Trypanosoma brucei | Tb927.3.4910 | signal peptide peptidase, putative |
Trypanosoma congolense | TcIL3000_3_2960 | signal peptide peptidase, putative |
Trypanosoma cruzi | TcCLB.507951.260 | signal peptide peptidase, putative |
Toxoplasma gondii | TGME49_237150 | minor histocompatibility antigen h13, putative |
Trichomonas vaginalis | TVAG_074490 | Clan AD, family A22, presenilin-like aspartic peptidase |
Gene/Ortholog | Organism | Phenotype | Source Study |
---|---|---|---|
Tb927.3.4910 | Trypanosoma brucei | significant loss of fitness in bloodstream forms (3 days) | alsford |
Tb927.3.4910 | Trypanosoma brucei | significant loss of fitness in bloodstream forms (6 days) | alsford |
Tb927.3.4910 | Trypanosoma brucei | no significant loss or gain of fitness in procyclic forms | alsford |
Tb927.3.4910 | Trypanosoma brucei | no significant loss or gain of fitness in differentiation of procyclic to bloodstream forms | alsford |
CELE_T05E11.5 | Caenorhabditis elegans | embryonic lethal | wormbase |
CELE_T05E11.5 | Caenorhabditis elegans | larval arrest | wormbase |
CELE_T05E11.5 | Caenorhabditis elegans | larval lethal | wormbase |
CELE_T05E11.5 | Caenorhabditis elegans | slow growth | wormbase |
PBANKA_1320700 | Plasmodium berghei | Essential | plasmo |
TGME49_237150 | Toxoplasma gondii | Probably essential | sidik |
keio | Systematic single-gene knock-out mutants of E. coli K12 | The Keio Collection |
wormbase | C. elegans RNAi experiments | WormBase web site, http://www.wormbase.org, release WS170 |
yeastgenome | Systematic deletion of yeast genes | Saccharomyces Genome Database |
blattner | Systematic mutagenesis of the E. coli (MG1655) genome | J Bacteriol 2004, 186:4921-4930 |
shigen | Profiling of E. coli Chromosome (PEC) | National Institute of Genetics, Japan |
neb | C. elegans RNAi phenotypes | Data obtained from Wormbase WS150, curated by K. Chaudary and T. Carlow, New England Biolabs |
gerdes | Experimental determination and system-level analysis of essential genes in E. coli MG1655 | Gerdes et al., J Bacteriol. 2003 185:5673-84 |
alsford | High-throughput phenotyping using parallel sequencing of RNA interference targets in the African trypanosome | Genome Res 2011, 21:915-924 |
nmpdr | Genome-scale essentiality datasets from published studies (M. tuberculosis) | National Microbial Pathogen Data Resource |
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
In any case, if you have information about papers containing relevant validation data for this target, please contact us.